BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 26999116)

  • 1. Influence of Long-Distance Bicycle Riding on Serum/Urinary Biomarkers of Prostate Cancer.
    Heger Z; Gumulec J; Ondrak A; Skoda J; Zitka Z; Cernei N; Masarik M; Zitka O; Adam V
    Int J Mol Sci; 2016 Mar; 17(3):377. PubMed ID: 26999116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum sarcosine increases the accuracy of prostate cancer detection in patients with total serum PSA less than 4.0 ng/ml.
    Lucarelli G; Fanelli M; Larocca AM; Germinario CA; Rutigliano M; Vavallo A; Selvaggi FP; Bettocchi C; Battaglia M; Ditonno P
    Prostate; 2012 Nov; 72(15):1611-21. PubMed ID: 22430630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long distance bicycle riding causes prostate-specific antigen to increase in men aged 50 years and over.
    Mejak SL; Bayliss J; Hanks SD
    PLoS One; 2013; 8(2):e56030. PubMed ID: 23418500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spondin-2, a secreted extracellular matrix protein, is a novel diagnostic biomarker for prostate cancer.
    Lucarelli G; Rutigliano M; Bettocchi C; Palazzo S; Vavallo A; Galleggiante V; Trabucco S; Di Clemente D; Selvaggi FP; Battaglia M; Ditonno P
    J Urol; 2013 Dec; 190(6):2271-7. PubMed ID: 23665271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-distance mountain biking does not disturb the measurement of total, free or complexed prostate-specific antigen in healthy men.
    Herrmann M; Scharhag J; Sand-Hill M; Kindermann W; Herrmann W
    Clin Chem Lab Med; 2004 Mar; 42(3):347-9. PubMed ID: 15080570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case control study of sarcosine as an early prostate cancer detection biomarker.
    Ankerst DP; Liss M; Zapata D; Hoefler J; Thompson IM; Leach RJ
    BMC Urol; 2015 Oct; 15():99. PubMed ID: 26429735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rigorous bicycling does not increase serum levels of total and free prostate-specific antigen (PSA), the free/total PSA ratio, gonadotropin levels, or uroflowmetric parameters.
    Saka T; Sofikerim M; Demirtas A; Kulaksizoglu S; Caniklioglu M; Karacagil M
    Urology; 2009 Dec; 74(6):1325-30. PubMed ID: 19781750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New challenges and earlier approved methods in the laboratory diagnosis of prostate cancer].
    Kovács GL
    Magy Onkol; 2014 Dec; 58(4):301-9. PubMed ID: 25517448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percent free PSA as an additional measure in a prostate cancer screen.
    Miele ME
    Clin Lab Sci; 2001; 14(2):102-7. PubMed ID: 15625982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efforts to resolve the contradictions in early diagnosis of prostate cancer: a comparison of different algorithms of sarcosine in urine.
    Cao DL; Ye DW; Zhu Y; Zhang HL; Wang YX; Yao XD
    Prostate Cancer Prostatic Dis; 2011 Jun; 14(2):166-72. PubMed ID: 21321584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Total and free PSA serum concentrations are not influenced by extensive physical exercise and bicycle riding.
    Lippi G; Corgnati A; Salvagno G; Schena F; Franchini M; Guidi G
    Int J Sports Med; 2005; 26(1):79-81. PubMed ID: 15643540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Urinary Sarcosine/Creatinine Ratio is a Potential Diagnostic and Prognostic Marker in Prostate Cancer.
    Wang M; Zou L; Liang J; Wang X; Zhang D; Fang Y; Zhang J; Xiao F; Liu M
    Med Sci Monit; 2018 May; 24():3034-3041. PubMed ID: 29741162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bicycle riding has no important impact on total and free prostate-specific antigen serum levels in older men.
    Luboldt HJ; Peck KD; Oberpenning F; Schmid HP; Semjonow A
    Urology; 2003 Jun; 61(6):1177-80. PubMed ID: 12809893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ratio of alpha 1-antichymotrypsin--prostate specific antigen to total prostate specific antigen in prostate cancer diagnosis.
    Lein M; Jung K; Elgeti U; Brux B; Sinha P; Schnorr D; Loening SA
    Anticancer Res; 2000; 20(6D):4997-5001. PubMed ID: 11326657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of bicycle riding on serum prostate specific antigen levels.
    Crawford ED; Mackenzie SH; Safford HR; Capriola M
    J Urol; 1996 Jul; 156(1):103-5. PubMed ID: 8648767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Changes of serum total PSA and free PSA in patients with prostate carcinoma and benign prostate hyperplasia].
    Gao ZW; Liu G; Sheng BW
    Ai Zheng; 2004 Jun; 23(6):701-3. PubMed ID: 15191675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma sarcosine does not distinguish early and advanced stages of prostate cancer.
    Bohm L; Serafin AM; Fernandez P; Van der Watt G; Bouic PJ; Harvey J
    S Afr Med J; 2012 Jun; 102(8):677-9. PubMed ID: 22831945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate-specific antigen (PSA) isoform p2PSA significantly improves the prediction of prostate cancer at initial extended prostate biopsies in patients with total PSA between 2.0 and 10 ng/ml: results of a prospective study in a clinical setting.
    Guazzoni G; Nava L; Lazzeri M; Scattoni V; Lughezzani G; Maccagnano C; Dorigatti F; Ceriotti F; Pontillo M; Bini V; Freschi M; Montorsi F; Rigatti P
    Eur Urol; 2011 Aug; 60(2):214-22. PubMed ID: 21482022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic validity of macrophage migration inhibitory factor in serum of patients with prostate cancer: a re-evaluation.
    Michael A; Stephan C; Kristiansen G; Burckhardt M; Loening SA; Schnorr D; Jung K
    Prostate; 2005 Jan; 62(1):34-9. PubMed ID: 15389818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk assessment for biochemical recurrence prior to radical prostatectomy: significant enhancement contributed by human glandular kallikrein 2 (hK2) and free prostate specific antigen (PSA) in men with moderate PSA-elevation in serum.
    Steuber T; Vickers AJ; Haese A; Becker C; Pettersson K; Chun FK; Kattan MW; Eastham JA; Scardino PT; Huland H; Lilja H
    Int J Cancer; 2006 Mar; 118(5):1234-40. PubMed ID: 16152616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.